Sonic Healthcare Limited (ASX:SHL)
Australia
· Delayed Price · Currency is AUD 22.80
-0.40 (-1.72%)
At close: Mar 6, 2026
Sonic Healthcare Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Revenue | 10,422 | 9,645 | 8,967 | 8,169 | 9,340 | 8,754 | Upgrade
|
| Revenue Growth (YoY) | 11.70% | 7.56% | 9.77% | -12.54% | 6.69% | 28.14% | Upgrade
|
| Cost of Revenue | 7,000 | 6,457 | 6,023 | 5,327 | 5,614 | 5,328 | Upgrade
|
| Gross Profit | 3,422 | 3,188 | 2,945 | 2,842 | 3,726 | 3,426 | Upgrade
|
| Selling, General & Admin | 305.32 | 267.56 | 249.79 | 217.02 | 206.13 | 247.72 | Upgrade
|
| Amortization of Goodwill & Intangibles | 96.11 | 92.85 | 82.92 | 71.63 | 67.99 | 68.2 | Upgrade
|
| Other Operating Expenses | 1,281 | 1,169 | 1,068 | 904.26 | 687.67 | 615.78 | Upgrade
|
| Operating Expenses | 2,433 | 2,252 | 2,095 | 1,824 | 1,569 | 1,505 | Upgrade
|
| Operating Income | 989.25 | 936.19 | 849.66 | 1,018 | 2,157 | 1,921 | Upgrade
|
| Interest Expense | -197.78 | -180.51 | -151.35 | -87.03 | -79.82 | -92.52 | Upgrade
|
| EBT Excluding Unusual Items | 791.48 | 755.69 | 698.31 | 931.19 | 2,077 | 1,829 | Upgrade
|
| Merger & Restructuring Charges | -12.59 | -4.82 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 32.34 | - | - | - | Upgrade
|
| Pretax Income | 778.88 | 750.87 | 730.65 | 931.19 | 2,077 | 1,829 | Upgrade
|
| Income Tax Expense | 213.24 | 206.94 | 186.85 | 223.26 | 561.74 | 480.94 | Upgrade
|
| Earnings From Continuing Operations | 565.64 | 543.92 | 543.8 | 707.93 | 1,515 | 1,348 | Upgrade
|
| Minority Interest in Earnings | -26.24 | -30.33 | -32.71 | -22.95 | -54.9 | -32.62 | Upgrade
|
| Net Income | 539.4 | 513.6 | 511.09 | 684.98 | 1,461 | 1,315 | Upgrade
|
| Net Income to Common | 539.4 | 513.6 | 511.09 | 684.98 | 1,461 | 1,315 | Upgrade
|
| Net Income Growth | -1.11% | 0.49% | -25.39% | -53.10% | 11.07% | 149.18% | Upgrade
|
| Shares Outstanding (Basic) | 487 | 480 | 476 | 470 | 478 | 477 | Upgrade
|
| Shares Outstanding (Diluted) | 488 | 481 | 477 | 472 | 483 | 481 | Upgrade
|
| Shares Change (YoY) | 1.59% | 0.91% | 0.96% | -2.16% | 0.29% | 0.90% | Upgrade
|
| EPS (Basic) | 1.11 | 1.07 | 1.07 | 1.46 | 3.05 | 2.75 | Upgrade
|
| EPS (Diluted) | 1.11 | 1.07 | 1.07 | 1.45 | 3.02 | 2.73 | Upgrade
|
| EPS Growth | -2.75% | -0.47% | -26.07% | -52.07% | 10.76% | 146.93% | Upgrade
|
| Free Cash Flow | 865.97 | 960.55 | 600.9 | 1,082 | 1,939 | 1,769 | Upgrade
|
| Free Cash Flow Per Share | 1.77 | 2.00 | 1.26 | 2.29 | 4.01 | 3.67 | Upgrade
|
| Dividend Per Share | 1.080 | 1.070 | 1.060 | 1.040 | 1.000 | 0.910 | Upgrade
|
| Dividend Growth | 0.94% | 0.94% | 1.92% | 4.00% | 9.89% | 7.06% | Upgrade
|
| Gross Margin | 32.84% | 33.05% | 32.84% | 34.80% | 39.90% | 39.14% | Upgrade
|
| Operating Margin | 9.49% | 9.71% | 9.47% | 12.46% | 23.09% | 21.95% | Upgrade
|
| Profit Margin | 5.18% | 5.33% | 5.70% | 8.38% | 15.64% | 15.02% | Upgrade
|
| Free Cash Flow Margin | 8.31% | 9.96% | 6.70% | 13.24% | 20.76% | 20.21% | Upgrade
|
| EBITDA | 1,328 | 1,244 | 1,152 | 1,281 | 2,413 | 2,159 | Upgrade
|
| EBITDA Margin | 12.74% | 12.90% | 12.84% | 15.68% | 25.83% | 24.66% | Upgrade
|
| D&A For EBITDA | 338.55 | 307.58 | 301.97 | 262.67 | 255.73 | 237.94 | Upgrade
|
| EBIT | 989.25 | 936.19 | 849.66 | 1,018 | 2,157 | 1,921 | Upgrade
|
| EBIT Margin | 9.49% | 9.71% | 9.47% | 12.46% | 23.09% | 21.95% | Upgrade
|
| Effective Tax Rate | 27.38% | 27.56% | 25.57% | 23.98% | 27.04% | 26.30% | Upgrade
|
| Revenue as Reported | 9,645 | 9,645 | 9,000 | 8,169 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.